Blocking cytokines with genes

Journal of Leukocyte Biology

Volumn 64, Issue 1, 1998, Pages 55-61

  Evans, C H ^a   Ghivizzani, S C ^a   Robbins, P D ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Gene therapy; Inflammation

Indexed keywords

GENE PRODUCT; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; CLONING VECTOR; CONFERENCE PAPER; GENE EXPRESSION REGULATION; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; TRANSGENE;

ANIMALIA; EQUIDAE;

EID: 0031777629     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.64.1.55     Document Type: Conference Paper

References (61)

1. Arend, W. P. (1991) Interleukin-1 receptor antagonist: a new member of the interleukin family. J. Clin. Invest. 88, 1445-1451.
2. Symons, J. A., Eastgate, J. A., Duff, G. W. (1991) Purification and characterization of a novel soluble receptor for interleukin-1. J. Exp. Med. 174, 1251-1254.
3. Mohler, K. M., Torrance, D. S., Smith, C. A., Goodwin, R. G., Stremler, K. E., Fung, V. P., Madani, H., Widmer, M. B. (1993) Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immunol. 151, 1548-1561.
4. Robbins, P. D., Evans, C. H. (1996) Prospects for treating autoimmune and inflammatory diseases by gene therapy. Gene Ther. 3, 187-189.
5. Evans, C. H., Robbins, P. D. (1996) Pathways to gene therapy in rheumatoid arthritis. Curr. Op. Rheumatol. 8, 230-234.
6. Evans, C. H., Ghivizzani, S. C., Whalen, J. D., Robbins, P. D. Gene therapy in autoimmune diseases. Ann. Rheum. Dis., in press.
7. Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Deck, R. R., DeWitt, C. M., Friedman, A., Hawe, L. A., Leander, K. R., Martinez, D., Perry, H. C., Shiver, J. W., Montgomery, D. L., Liu, M. A. (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749.
8. Robbins, P. D. (ed.) (1996) Gene Therapy Protocols. Totowa. NJ: Humana Press.
9. Bandara, G., Mueller, G. M., Galea-Lauri, J., Tindal, M. H., Georgescu, H. I., Surhanek, M. K., Hung, G. L., Glorioso, J. C., Robbins, P. D., Evans, C. H. (1993) Intraarticular expression of biologically active interleukin-1 receptor antagonist protein by ex vivo gene transfer. Proc. Natl. Acad. Sci. USA 90, 10764-10768.
10. Kang, R., Marui, T., Ghivizzani, S. C., Nita, I. M., Georgescu, H. I., Suh, J-K., Robbins, P. D., Evans, C. H. (1997) Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: a feasibility study. Osteoarth. Cart. 5, 139-143.
11. Tripathy, S. K., Black, H. B., Goldwasser, E., Leiden, J. M. (1996) Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Med. 2, 545-550.
12. Yang, Y., Nunes, F. A., Berenesi, K., Furth, E. E., Gonezol, E., Wilson, J. M. (1994) Cellular immunity to viral antigens limits E1-deleted adenoviruses of gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.
13. Palmer, T. D., Rosman, G. J., Osborne, W. R., Miller, A. D. (1991) Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc. Natl. Acad. Sci. USA 88, 1330-1334.
14. Boggs, S. S., Patrene, K. D., Mueller, G. M., Evans, C. H., Doughty, L. A., Robbins, P. D. (1995) Prolonged systemic expression of human IL-1 receptor antagonist protein in sera of lethally irradiated mice reconstituted with hematopoietic stem cells transduced with a retrovirus containing the IL-1ra gene. Gene Ther. 2, 632-638.
15. Barranger, J. A., Rice, E., Sansieri, C., Bahnson, A., Mohney, T., Swaney, N., Dunigan, J., Beeler, M., Lucot, S., Shierer-Fochler, S., Ball, E. (1998) Transfer of the glucocerebrosidase gene to CD34 cells and their autologous transplantation in patients with Gaucher Disease. Blood 90, 405.
16. Christ, M., Lusky, M., Stoeckel, F., Dreyer, D., Dieterle, A., Michou, A. I., Pavirani, A., Mehtali, M. (1997) Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response. Immunol. Lett. 57, 19-25.
17. Glorioso, J. C., Krisky, D., Marconi, P., Oligino, T., Ghivizzani, S. C., Robbins, P. D., Schmidt, M. C., Goins, W. F., Evans, C. (1997) Progress in development of herpes simplex virus gene vectors for treatment of rheumatoid arthritis. Adv. Drug Del. Rev. 27, 41-57.
18. Challita, P. M., Kohn, D. B. (1994) Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci. USA 91, 2567-2571.
19. Scharfman, R., Axelrod, J. H., Verma, I. M. (1991) Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc. Natl. Acad. Sci. USA 88, 4626-1630.
20. Gossen, M., Freundlieb, S., Bender, G. Müller, G., Hillen, W., Bujard, H. (1995) Transcriptional activation of tetracyclines in mammalian cells. Science 268, 1766-1769.
21. Wang, Y., O'Malley, B. W., Tsai, S. Y., O'Malley, B. W. (1994) A regulatory system for use in gene transfer. Proc. Natl. Acad. Sci. USA 91, 8180-8184.
22. Bandara, G., Robbins, P. D., Georgescu, H. I., Mueller, G. M., Glorioso, J. C., Evans, C. H. (1992) Gene transfer to synoviocytes: prospects for gene treatment for arthritis. DNA Cell Biol. 11, 227-231.
23. Evans, C. H., Robbins, P. D. (1997) Getting genes into human synovium. J. Rheumatol. 24, 2061-2063.
24. Otani, K., Nita, I., Macaulay, W., Georgescu, H. I., Robbins, P. D., Evans, C. H. (1996) Suppression of antigen-induced arthritis by gene therapy. J. Immunol. 156, 3558-3562.
25. Makarov, S. S., Olsen, J. C., Johnston, W. N., Anderle, S. K., Brown, R. R., Baldwin, A. S., Haskill, J. S., Schwab, J. H. (1996) Suppression of experimental arthritis by gene transfer of interleukin-1 receptor antagonist cDNA. Proc. Natl. Acad. Sci. USA 93, 402-106.
26. Bakker, A. C., Joosten, L. A. B., Arntz, O. J., Helsen, M. M. A., Benderle, A. M., Van De Loo, F. A. J., Van den Berg, W. B. (1997) Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheumatol. 40, 893-900.
27. Roessler, B. J., Alolen, E. D., Wilson, J. M., Hartman, J. W., Davidson, B. L. (1993) Adenoviral-mediated gene transfer to rabbit synovium in vivo. J. Clin. Invest. 92, 1085-1092.
28. Roessler, B. J., Hartman, J. W., Vallance, D. K., Latta, J. M., Janich, S. L., Davidson, B. L. (1995) Inhibition of interleukin-1 induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector. Hum. Gene Ther. 6, 307-316.
29. Nita, I., Ghivizzani, S. C., Galea-Lauri, J., Bandara, G., Georgescu, H. I., Robbins. P. D., Evans, C. H. (1996) Direct gene delivery to synovium: an evaluation of potential vectors in vitro and in vivo. Arthritis Rheumatol. 39, 820-828.
30. Sawchuck, S. J., Voivin, G. P., Duwel, L. E., Ball, W., Bove, K., Trapnell, B., Hirsch, R. (1996) Anti-T cell receptor monoclonal antibody prolongs transgene expression following adenovirus-mediated in vivo gene transfer to mouse synovium. Hum. Gene Ther. 7, 499-506.
31. Tomita, T., Hashimoto, H., Tomita, N., Morishita, R., Lee, S. B., Hayashida, K., Nakamura, N., Yonenobu, K., Kaneda, Y., Ochi, T. (1997) In vivo direct gene transfer into articualr cartilage by intraarticular injectio mediated by HVJ (Sendai virus) and liposomes. Arthritis Rheumatol. 40, 901-906.
32. Yovandich, J., O'Malley B., Sikes, M., Ledley, F. D. (1995) Gene transfer to synovial cells by intraarticular administration of plasmid DNA. Hum. Gene Ther. 6, 603-610.
33. Ghivizzani, S. C., Lechman, E. R., Kang, R., Tio, C. Kolls, J., Evans, L. H., Bobbins, P. D. (1998) Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor α soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc. Natl. Acad. Sci. USA 95, 4613-4618.
34. Whalen, J. D., Carlos, C. A., Bobbins, P. D., Evans, C. H. (1997) Periartieular gene therapy with viral IL-10 can prevent collagen-induced arthritis in mice. Arthritis Rheumatol. 40 (Suppl.), S158.
35. Makarov, S., Baldwin, A. S. (1996) Local suppression of NF-κB inhibits experimental arthritis in rats. Arthritis Rheumatol. 39 (Suppl.), S121 (Abstract 563).
36. Doherty, P. J. (1995) Gene therapy and arthritis. J. Rheumatol. 22, 1220-1223.
37. Zhang, H., Yang, Y., Horton, J. L., Samoilova, E. B., Judge, T. A., Turka, L. A., Wilson, J. M., Chen, Y. (1997) Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand expressing APCs as a therapy for autoimmune disease. J. Clin. Invest. 100, 1951-1957.
38. Zhang, H. G., Sun, D., Curiel, D. T., Mountz, J. D., Zhou, T. (1997) Transfusion of fas ligand expressing APCs as a therapy for autoimmune disease. Arthritis Rheumatol 40 (Suppl.) S172 (Abstract 850).
39. Chernajovsky, Y., Adams, G., Podhajcer, O., Mueller, G., Robbins, P. D., Feldman, M. (1995) Inhibition of transfer of collagen induced arthritis into SCID mice by gene transfer of spleen cells with retrovirus expressing soluble human tumor necrosis factor receptor. Gene Ther. 2, 731-735.
40. 1 ameliorate disease in a collagen-induced arthritis model. Gene Ther. 4, 553-559.
41. Shaw, M. K., Lorens, J. B., Dhawan, A., DalCanto, R., Tse, H. Y., Tran, A. B., Bonpane, C., Eswaran, S. L., Brocke, S., Sarventrick, N., Steinman, L., Nolan, G. P., Fathman, C. G. (1997) Local delivery of interleukin 4 by retrovirus-transduced T lympohcytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med. 185, 1711-1714.
42. Le, C. H., Nicolson, A. G., Morales, A., Sewell, K. L. (1997) Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor a receptor gene. Arthritis Rheumatol. 40, 1662-1669.
43. Ma. Y., Duwell, L. E.. Thornton. S., Bluestone, J. A., Hirsch. R. (1997) Viral interleukin-10 gene therapy inhibits collagen induced arthritis in mice. Arthritis Rheum. 40. (Suppl.) S158 (Abstract 75).
44. Jorgensen, C., Apparailly, F., Canovas. F., Jacquet, C., Verwaerde, C., Sany, J. (1997) Chondroprotective effect of gene transfer of IL-10 in type II collagen induced arthritis. Arthritis Rheumatol. 40. (Suppl.) S221 (Abstract 1140).
45. Raz, E., Dudler, J., Lotz, M., Baird, S. M., Berry, C. C., Eisenberg, R. A., Carson, D. A. (1995) Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery. Lupus 4, 286-292.
46. Giladi, E., Raz, E., Karmeli, F., Okon, E., Rachmilewitz, D. (1995) Transforming growth factor-β gene therapy ameliorates experimental colitis in rats. Eur. J. Gastroenterol. Hepatol. 7, 341-347.
47. 1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model. J. Clin. Invest. 101, 1-7.
48. Miyata, M., Sato, Y., Sato, H., Saito, A., Irisawa, A., Nishimaki, T., Kasukawa, B. (1997) Suppression of murine collagen-induced arthritis (c.i.a.) by inoculation of plasmid DNA encoding for interleukin (IL)-10. Arthritis Rheumatol. 40 (Suppl.), S55.
49. Müller-Ladner, U., Kriegsmann, J., Franklin, B., Matsumoto, S., Geiler, T., Gay, R. E., Gay, S. (1996) Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am. J. Pathol 149, 1607-1615.
50. Müller-Ladner, U., Roberts, C. R., Franklin, B. N., Gay, R. E., Robbins, P. D., Evans, C. H., Gay, S. (1997) Human IL-1Ra gene transfer into human synovial fibroblasts is chondroproteotive. J. Immunol. 158, 3492-3498.
51. Müller-Ladner, U., Franklin, B. N., Roberts, C. R., Robbins, P. D., Gay, R. E., Evans, C. H., Gay, S. (1996) Gene transfer of interleukin-10 into human synovial fibroblasts and implantation into the SCID mouse. Arthritis Rheumatol. 39 (Suppl.), S160.
52. Müller-Ladner, U., Roberts, C. R., Franklin, B. N., Gay, R. E., Robbins, P. D., Evans, C. H., Gay, S. (1996) Gene transfer of TNF-α receptor p55 into human synovial fibroblasts and implantation into the SCID mouse. Arthritis Rheumatol. 39 (Suppl.), S307.
53. Evans, C. H., Robbins, P. D., Ghivizzani, S. C., Herndon, J. H., Kang, R., Bahnson, A. B., Barranger, J. A., Elders, E. M., Gay, S., Tomaino, M. M., Wasko, M. C., Watkins, S. C., Whiteside, T. L., Glorioso, J. C., Lotze, M., Wright, T. M. (1996) Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum. Gene Ther. 7, 1261-1280.
54. Bessis, N., Boissier, M. C., Ferrara, P., Blankenstein, T., Fradelizi, D., Fournier, C. (1996) Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur. J. Immunol. 26, 2399-2403.
55. Pelletier, J. P., Caron, J. P., Evans, C. H., Robbins, P. D., Georgescu, H. I., Jovanovic, D., Fernandes, J. C., Pelletier, J. M (1997) In vivo suppression of early experimental osteoarthritis by IL-1Ra using gene therapy. Arthritis Rheum. 40, 1012-1019.
56. Daheshia, M., Kuklin, N., Kanangat, S., Manickan, E., Rouse, B. T. (1997) Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10. J. Immunol. 159, 1945-1952.
57. Rogy, M. A., Auffenberg, T., Espat, N. J., Philip, R., Remick, D., Wollenberg, G. K., Copeland, E. M., Moldawer, L. L. (1995) Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses. J. Exp. Med. 181, 2289-2293.
58. Xing, Z., Ohkawara, Y., Jordana, M., Graham, F. L., Gauldie, J. (1997) Adenoviral vector-mediated interleukin-10 expression in vivo: intramuscular gene transfer inhibits cytokine responses in endotoxemia. Gene Ther. 4, 140-149.
59. Doughty, L. A., Patrene, K. D., Evans, C. H., Boggs, S. S., Robbins, P. D. (1997) Constitutive expression of IL-1Ra or soluble TNF receptor by genetically modified hematopoietic cells suppresses LPS induction of IL-6 and IL-10. Gene Ther. 4, 252-257.
60. Conary, J. T., Parker, R. E., Chrisstman, B. W., Faulks, R. D., King, G. A., Meyrick, B. O., Brigham, K. L. (1994) Protection of rabbit lungs from endotoxin injury by in vivo hyperexpression of the prostaglandin G/H synthase gene. J. Clin. Invest. 93, 1834-1840.
61. Li, X. M., Chopra, R. K., Chou, T. Y., Schofield, B. H., Wills-Karp, M., Huang, S. K. (1996) Mucosal IFN-γ gene transfer inhibits pulmonary allergic responses in mice. J. Immunol. 157, 3216-3219.